G266-0660 Screening compound: ethyl 1-[1,3-dimethyl-6-({[(4-methylphenyl)methyl]carbamoyl}amino)-2-oxo-2,3-dihydro-1H-1,3-benzodiazol-5-yl]piperidine-4-carboxylate

G266-0660 Screening compound: ethyl 1-[1,3-dimethyl-6-({[(4-methylphenyl)methyl]carbamoyl}amino)-2-oxo-2,3-dihydro-1H-1,3-benzodiazol-5-yl]piperidine-4-carboxylate
G266-0660 Screening compound: ethyl 1-[1,3-dimethyl-6-({[(4-methylphenyl)methyl]carbamoyl}amino)-2-oxo-2,3-dihydro-1H-1,3-benzodiazol-5-yl]piperidine-4-carboxylate alternative view

Chemical Structure Depiction of ChemDiv screening compound G266-0660
ethyl 1-[1,3-dimethyl-6-({[(4-methylphenyl)methyl]carbamoyl}amino)-2-oxo-2,3-dihydro-1H-1,3-benzodiazol-5-yl]piperidine-4-carboxylate

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G266-0660

Molecular Formula

C26H33N5O4 (C26 H33 N5 O4)

Compound Name

ethyl 1-[1,3-dimethyl-6-({[(4-methylphenyl)methyl]carbamoyl}amino)-2-oxo-2,3-dihydro-1H-1,3-benzodiazol-5-yl]piperidine-4-carboxylate

IUPAC name

ethyl 1-[13-dimethyl-6-({[(4-methylphenyl)methyl]carbamoyl}amino)-2-oxo-23-dihydro-1H-13-benzodiazol-5-yl]piperidine-4-carboxylate

SMILES

CCOC(C(CC1)CCN1c(c(NC(NCc1ccc(C)cc1)=O)c1)cc(N2C)c1N(C)C2=O)=O

InChI

InChI=1S/C26H33N5O4/c1-5-35-24(32)19-10-12-31(13-11-19)21-15-23-22(29(3)26(34)30(23)4)14-20(21)28-25(33)27-16-18-8-6-17(2)7-9-18/h6-9,14-15,19H,5,10-13,16H2,1-4H3,(H2,27,28,33)

InChI Key

OBLLHVZAEDRLTC-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27211793

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

479.58

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

3.883

Distribution Coefficient, logD

3.879

Water Solubility, LogSw

-3.77

Polar Surface Area

74.756

Acid Dissociation Constant (pKa)

10.12

Base Dissociation Constant (pKb)

5.25

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

42.30

G266-0660 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

Antiviral Library (67538 compounds)

CNS Targets (44014 compounds)

Antibacterial Compounds Library (13827 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Antiviral
  • Infections
  • Immune system
  • Nervous system
  • Infections
  • Immune system
  • animal
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with G266-0660 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G266-0660?
Check Price and Availability of G266-0660, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G266-0660 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G266-0660
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G266-0660
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G266-0660 available by request